XML 117 R98.htm IDEA: XBRL DOCUMENT v3.4.0.3
Condensed Consolidating Financial Statements (Condensed Consolidating Statement of Cash Flows) (Details) - USD ($)
$ in Thousands
 3 Months Ended 12 Months Ended
Mar. 31, 2016
Dec. 31, 2015
Sep. 30, 2015
Jun. 30, 2015
Mar. 31, 2015
Dec. 31, 2014
Sep. 30, 2014
Jun. 30, 2014
Mar. 31, 2016
Mar. 31, 2015
Mar. 31, 2014
Operating Activities                      
Net income (loss) $ 13,936 $ 27,995 $ 31,803 $ 26,173 $ 23,772 $ 21,293 $ 16,463 $ 16,732 $ 99,907 $ 78,260 $ 72,615
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:                      
Depreciation and amortization                 23,676 17,740 13,486
Gain on sale of asset         0 $ (1,133) $ 0 0 0 (1,133) 0
Deferred income taxes                 46,152 28,922 19,012
Long term income taxes payable                 (332) 2,294 0
Amortization of debt origination costs                 8,994 8,821 10,512
Stock-based compensation costs                 9,954 6,918 5,146
Lease termination costs                 0 785 0
Loss on extinguishment of debt                 17,970 0 18,286
Premium payment on Senior Notes                     (15,527)
(Gain) loss on sale or disposal of property and equipment                 (35) 321 (3)
Equity in income of subsidiaries                 0 0 0
Changes in operating assets and liabilities, net of effects from acquisitions:                      
Accounts receivable                 1,824 1,608 9,735
Inventories                 (3,005) 15,360 (2,850)
Prepaid expenses and other current assets                 (7,921) 4,664 (2,130)
Accounts payable                 (11,348) (17,637) (4,641)
Accrued liabilities                 (1,328) 9,332 (12,059)
Net cash provided by operating activities                 174,350 156,255 111,582
Investing Activities                      
Purchases of property and equipment                 (3,568) (6,101) (2,764)
Proceeds from the sale of property and equipment                 344 0 3
Proceeds from sale of business                 0 18,500 0
Proceeds from sale of asset                   10,000  
Proceeds from Insight Pharmaceuticals working capital arbitration settlement                 7,237 0 0
Intercompany activity, net                 0 0 0
Net cash used in investing activities                 (222,971) (805,258) (57,976)
Financing Activities                      
Borrowings under Bridge term loans                 80,000 0 0
Repayments under Bridge term loans                 (80,000) 0 0
Term loan borrowings                 0 720,000 0
Term loan repayments                 (60,000) (130,000) (157,500)
Borrowings under revolving credit agreement                 115,000 124,600 50,000
Repayments under revolving credit agreement                 (96,100) (58,500) (83,000)
Payments of debt origination costs                 (11,828) (16,072) (7,466)
Proceeds from exercise of stock options                 6,689 3,954 5,907
Proceeds from restricted stock exercises                 544 57 0
Excess tax benefits from share-based awards                 1,960 1,330 1,650
Fair value of shares surrendered as payment of tax withholding                 (2,229) (2,104) (744)
Intercompany activity, net                 0 0 0
Net cash (used in) provided by financing activities                 54,036 643,265 (41,153)
Effects of exchange rate changes on cash and cash equivalents                 497 (1,275) 208
Increase (decrease) in cash and cash equivalents                 5,912 (7,013) 12,661
Cash and cash equivalents - beginning of year       21,318       28,331 21,318 28,331 15,670
Cash and cash equivalents - end of year 27,230       21,318       27,230 21,318 28,331
Prestige Brands Holdings, Inc.                      
Operating Activities                      
Net income (loss)                 99,907 78,260 72,615
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:                      
Depreciation and amortization                 4,050 3,381 2,994
Gain on sale of asset                   0  
Deferred income taxes                 136 (192) (42)
Long term income taxes payable                 0 0  
Amortization of debt origination costs                 0 0 0
Stock-based compensation costs                 9,794 6,918 5,146
Lease termination costs                   0  
Loss on extinguishment of debt                 0   0
Premium payment on Senior Notes                     0
(Gain) loss on sale or disposal of property and equipment                 0 0 0
Equity in income of subsidiaries                 (98,803) (76,383) (66,739)
Changes in operating assets and liabilities, net of effects from acquisitions:                      
Accounts receivable                 0 473 (452)
Inventories                 0 0 0
Prepaid expenses and other current assets                 (9,580) 2,273 (3,062)
Accounts payable                 929 (2,457) 1,815
Accrued liabilities                 1,907 2,650 (4,966)
Net cash provided by operating activities                 8,340 14,923 7,309
Investing Activities                      
Purchases of property and equipment                 (2,460) (5,029) (2,351)
Proceeds from the sale of property and equipment                 0   0
Proceeds from sale of business                   0  
Proceeds from sale of asset                   0  
Intercompany activity, net                 0 0 0
Net cash used in investing activities                 (2,460) (5,029) (2,351)
Financing Activities                      
Borrowings under Bridge term loans                 0    
Repayments under Bridge term loans                 0    
Term loan borrowings                   0  
Term loan repayments                 0 0 0
Borrowings under revolving credit agreement                 0 0 0
Repayments under revolving credit agreement                 0 0 0
Payments of debt origination costs                 0 0 0
Proceeds from exercise of stock options                 6,689 3,954 5,907
Proceeds from restricted stock exercises                 544 57  
Excess tax benefits from share-based awards                 1,960 1,330 1,650
Fair value of shares surrendered as payment of tax withholding                 (2,229) (2,104) (744)
Intercompany activity, net                 (19,791) (26,388) (1,847)
Net cash (used in) provided by financing activities                 (12,827) (23,151) 4,966
Effects of exchange rate changes on cash and cash equivalents                 0 0 0
Increase (decrease) in cash and cash equivalents                 (6,947) (13,257) 9,924
Cash and cash equivalents - beginning of year       11,387       24,644 11,387 24,644 14,720
Cash and cash equivalents - end of year 4,440       11,387       4,440 11,387 24,644
Prestige Brands, Inc., the issuer                      
Operating Activities                      
Net income (loss)                 90,201 77,881 62,560
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:                      
Depreciation and amortization                 594 592 577
Gain on sale of asset                   0  
Deferred income taxes                 1,272 2,462 1,466
Long term income taxes payable                 0 0  
Amortization of debt origination costs                 8,994 8,821 10,512
Stock-based compensation costs                 0 0 0
Lease termination costs                   0  
Loss on extinguishment of debt                 17,970   18,286
Premium payment on Senior Notes                     (15,527)
(Gain) loss on sale or disposal of property and equipment                 0 0 0
Equity in income of subsidiaries                 (70,953) (51,573) (53,836)
Changes in operating assets and liabilities, net of effects from acquisitions:                      
Accounts receivable                 2,514 (294) (370)
Inventories                 (744) 5,690 (3,193)
Prepaid expenses and other current assets                 (116) (28) (20)
Accounts payable                 814 (829) (2,942)
Accrued liabilities                 (2,749) 1,384 (3,835)
Net cash provided by operating activities                 37,639 44,106 13,678
Investing Activities                      
Purchases of property and equipment                 (93) (119) (119)
Proceeds from the sale of property and equipment                 0   0
Proceeds from sale of business                   0  
Proceeds from sale of asset                   0  
Intercompany activity, net                 (228,343) (809,157) (55,215)
Net cash used in investing activities                 (228,436) (809,276) (55,334)
Financing Activities                      
Borrowings under Bridge term loans                 80,000    
Repayments under Bridge term loans                 (80,000)    
Term loan borrowings                   720,000  
Term loan repayments                 (60,000) (130,000) (157,500)
Borrowings under revolving credit agreement                 115,000 124,600 50,000
Repayments under revolving credit agreement                 (96,100) (58,500) (83,000)
Payments of debt origination costs                 (11,828) (16,072) (7,466)
Proceeds from exercise of stock options                 0 0 0
Proceeds from restricted stock exercises                 0 0  
Excess tax benefits from share-based awards                 0 0 0
Fair value of shares surrendered as payment of tax withholding                 0 0 0
Intercompany activity, net                 143,725 125,142 89,622
Net cash (used in) provided by financing activities                 190,797 765,170 41,656
Effects of exchange rate changes on cash and cash equivalents                 0 0 0
Increase (decrease) in cash and cash equivalents                 0 0 0
Cash and cash equivalents - beginning of year       0       0 0 0 0
Cash and cash equivalents - end of year 0       0       0 0 0
Combined Subsidiary Guarantors                      
Operating Activities                      
Net income (loss)                 78,941 50,209 59,025
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:                      
Depreciation and amortization                 18,617 12,752 9,715
Gain on sale of asset                   (1,133)  
Deferred income taxes                 45,070 26,795 17,765
Long term income taxes payable                 (332) 2,294  
Amortization of debt origination costs                 0 0 0
Stock-based compensation costs                 0 0 0
Lease termination costs                   785  
Loss on extinguishment of debt                 0   0
Premium payment on Senior Notes                     0
(Gain) loss on sale or disposal of property and equipment                 1 0 (3)
Equity in income of subsidiaries                 (8,564) (2,013) (4,052)
Changes in operating assets and liabilities, net of effects from acquisitions:                      
Accounts receivable                 (388) 5,146 12,460
Inventories                 213 8,981 2,165
Prepaid expenses and other current assets                 1,977 2,631 711
Accounts payable                 (11,284) (16,734) (4,142)
Accrued liabilities                 (1,943) 3,560 (2,664)
Net cash provided by operating activities                 122,308 93,273 90,980
Investing Activities                      
Purchases of property and equipment                 (521) (739) (108)
Proceeds from the sale of property and equipment                 0   3
Proceeds from sale of business                   18,500  
Proceeds from sale of asset                   10,000  
Intercompany activity, net                 228,343 731,166 0
Net cash used in investing activities                 8,075 9,261 (105)
Financing Activities                      
Borrowings under Bridge term loans                 0    
Repayments under Bridge term loans                 0    
Term loan borrowings                   0  
Term loan repayments                 0 0 0
Borrowings under revolving credit agreement                 0 0 0
Repayments under revolving credit agreement                 0 0 0
Payments of debt origination costs                 0 0 0
Proceeds from exercise of stock options                 0 0 0
Proceeds from restricted stock exercises                 0 0  
Excess tax benefits from share-based awards                 0 0 0
Fair value of shares surrendered as payment of tax withholding                 0 0 0
Intercompany activity, net                 (127,484) (102,534) (90,875)
Net cash (used in) provided by financing activities                 (127,484) (102,534) (90,875)
Effects of exchange rate changes on cash and cash equivalents                 0 0 0
Increase (decrease) in cash and cash equivalents                 2,899 0 0
Cash and cash equivalents - beginning of year       0       0 0 0 0
Cash and cash equivalents - end of year 2,899       0       2,899 0 0
Combined Non-Guarantor Subsidiaries                      
Operating Activities                      
Net income (loss)                 8,564 2,013 4,052
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:                      
Depreciation and amortization                 415 1,015 200
Gain on sale of asset                   0  
Deferred income taxes                 (326) (143) (177)
Long term income taxes payable                 0 0  
Amortization of debt origination costs                 0 0 0
Stock-based compensation costs                 160 0 0
Lease termination costs                   0  
Loss on extinguishment of debt                 0   0
Premium payment on Senior Notes                     0
(Gain) loss on sale or disposal of property and equipment                 (36) 321 0
Equity in income of subsidiaries                 0 0 0
Changes in operating assets and liabilities, net of effects from acquisitions:                      
Accounts receivable                 (302) (3,717) (1,903)
Inventories                 (1,860) 555 (2,832)
Prepaid expenses and other current assets                 (202) (212) 241
Accounts payable                 (1,807) 2,383 628
Accrued liabilities                 1,457 1,738 (594)
Net cash provided by operating activities                 6,063 3,953 (385)
Investing Activities                      
Purchases of property and equipment                 (494) (214) (186)
Proceeds from the sale of property and equipment                 344   0
Proceeds from sale of business                   0  
Proceeds from sale of asset                   0  
Intercompany activity, net                 0 77,991 55,215
Net cash used in investing activities                 (150) (214) (186)
Financing Activities                      
Borrowings under Bridge term loans                 0    
Repayments under Bridge term loans                 0    
Term loan borrowings                   0  
Term loan repayments                 0 0 0
Borrowings under revolving credit agreement                 0 0 0
Repayments under revolving credit agreement                 0 0 0
Payments of debt origination costs                 0 0 0
Proceeds from exercise of stock options                 0 0 0
Proceeds from restricted stock exercises                 0 0  
Excess tax benefits from share-based awards                 0 0 0
Fair value of shares surrendered as payment of tax withholding                 0 0 0
Intercompany activity, net                 3,550 3,780 3,100
Net cash (used in) provided by financing activities                 3,550 3,780 3,100
Effects of exchange rate changes on cash and cash equivalents                 497 (1,275) 208
Increase (decrease) in cash and cash equivalents                 9,960 6,244 2,737
Cash and cash equivalents - beginning of year       9,931       3,687 9,931 3,687 950
Cash and cash equivalents - end of year 19,891       9,931       19,891 9,931 3,687
Eliminations                      
Operating Activities                      
Net income (loss)                 (177,706) (130,103) (125,637)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:                      
Depreciation and amortization                 0 0 0
Gain on sale of asset                   0  
Deferred income taxes                 0 0 0
Long term income taxes payable                 0 0  
Amortization of debt origination costs                 0 0 0
Stock-based compensation costs                 0 0 0
Lease termination costs                   0  
Loss on extinguishment of debt                 0   0
Premium payment on Senior Notes                     0
(Gain) loss on sale or disposal of property and equipment                 0 0 0
Equity in income of subsidiaries                 178,320 129,969 124,627
Changes in operating assets and liabilities, net of effects from acquisitions:                      
Accounts receivable                 0 0 0
Inventories                 (614) 134 1,010
Prepaid expenses and other current assets                 0 0 0
Accounts payable                 0 0 0
Accrued liabilities                 0 0 0
Net cash provided by operating activities                 0 0 0
Investing Activities                      
Purchases of property and equipment                 0 0 0
Proceeds from the sale of property and equipment                 0   0
Proceeds from sale of business                   0  
Proceeds from sale of asset                   0  
Intercompany activity, net                 0 0 0
Net cash used in investing activities                 0 0 0
Financing Activities                      
Borrowings under Bridge term loans                 0    
Repayments under Bridge term loans                 0    
Term loan borrowings                   0  
Term loan repayments                 0 0 0
Borrowings under revolving credit agreement                 0 0 0
Repayments under revolving credit agreement                 0 0 0
Payments of debt origination costs                 0 0 0
Proceeds from exercise of stock options                 0 0 0
Proceeds from restricted stock exercises                 0 0  
Excess tax benefits from share-based awards                 0 0 0
Fair value of shares surrendered as payment of tax withholding                 0 0 0
Intercompany activity, net                 0 0 0
Net cash (used in) provided by financing activities                 0 0 0
Effects of exchange rate changes on cash and cash equivalents                 0 0 0
Increase (decrease) in cash and cash equivalents                 0 0 0
Cash and cash equivalents - beginning of year       $ 0       $ 0 0 0 0
Cash and cash equivalents - end of year $ 0       $ 0       0 0 0
Care Pharma                      
Investing Activities                      
Acquisitions, less cash acquired                 0 0 (55,215)
Care Pharma | Prestige Brands Holdings, Inc.                      
Investing Activities                      
Acquisitions, less cash acquired                     0
Care Pharma | Prestige Brands, Inc., the issuer                      
Investing Activities                      
Acquisitions, less cash acquired                     0
Care Pharma | Combined Subsidiary Guarantors                      
Investing Activities                      
Acquisitions, less cash acquired                     0
Care Pharma | Combined Non-Guarantor Subsidiaries                      
Investing Activities                      
Acquisitions, less cash acquired                     (55,215)
Care Pharma | Eliminations                      
Investing Activities                      
Acquisitions, less cash acquired                     0
Insight Pharmaceuticals                      
Investing Activities                      
Proceeds from Insight Pharmaceuticals working capital arbitration settlement                 7,237    
Acquisitions, less cash acquired                 0 (749,666) 0
Insight Pharmaceuticals | Prestige Brands Holdings, Inc.                      
Investing Activities                      
Proceeds from Insight Pharmaceuticals working capital arbitration settlement                 0    
Acquisitions, less cash acquired                   0  
Insight Pharmaceuticals | Prestige Brands, Inc., the issuer                      
Investing Activities                      
Proceeds from Insight Pharmaceuticals working capital arbitration settlement                 0    
Acquisitions, less cash acquired                   0  
Insight Pharmaceuticals | Combined Subsidiary Guarantors                      
Investing Activities                      
Proceeds from Insight Pharmaceuticals working capital arbitration settlement                 7,237    
Acquisitions, less cash acquired                   (749,666)  
Insight Pharmaceuticals | Combined Non-Guarantor Subsidiaries                      
Investing Activities                      
Proceeds from Insight Pharmaceuticals working capital arbitration settlement                 0    
Acquisitions, less cash acquired                   0  
Insight Pharmaceuticals | Eliminations                      
Investing Activities                      
Proceeds from Insight Pharmaceuticals working capital arbitration settlement                 0    
Acquisitions, less cash acquired                   0  
Hydralyte                      
Investing Activities                      
Acquisitions, less cash acquired                 0 (77,991) 0
Hydralyte | Prestige Brands Holdings, Inc.                      
Investing Activities                      
Acquisitions, less cash acquired                   0  
Hydralyte | Prestige Brands, Inc., the issuer                      
Investing Activities                      
Acquisitions, less cash acquired                   0  
Hydralyte | Combined Subsidiary Guarantors                      
Investing Activities                      
Acquisitions, less cash acquired                   0  
Hydralyte | Combined Non-Guarantor Subsidiaries                      
Investing Activities                      
Acquisitions, less cash acquired                   (77,991)  
Hydralyte | Eliminations                      
Investing Activities                      
Acquisitions, less cash acquired                   0  
DenTek Oral Care, Inc.                      
Investing Activities                      
Acquisitions, less cash acquired                 (226,984) 0 0
DenTek Oral Care, Inc. | Prestige Brands Holdings, Inc.                      
Investing Activities                      
Acquisitions, less cash acquired                 0    
DenTek Oral Care, Inc. | Prestige Brands, Inc., the issuer                      
Investing Activities                      
Acquisitions, less cash acquired                 0    
DenTek Oral Care, Inc. | Combined Subsidiary Guarantors                      
Investing Activities                      
Acquisitions, less cash acquired                 (226,984)    
DenTek Oral Care, Inc. | Combined Non-Guarantor Subsidiaries                      
Investing Activities                      
Acquisitions, less cash acquired                 0    
DenTek Oral Care, Inc. | Eliminations                      
Investing Activities                      
Acquisitions, less cash acquired                 0    
2013 Senior Notes                      
Financing Activities                      
Proceeds from issuance of Senior Notes                 0 0 400,000
2013 Senior Notes | Prestige Brands Holdings, Inc.                      
Financing Activities                      
Proceeds from issuance of Senior Notes                     0
2013 Senior Notes | Prestige Brands, Inc., the issuer                      
Financing Activities                      
Proceeds from issuance of Senior Notes                     400,000
2013 Senior Notes | Combined Subsidiary Guarantors                      
Financing Activities                      
Proceeds from issuance of Senior Notes                     0
2013 Senior Notes | Combined Non-Guarantor Subsidiaries                      
Financing Activities                      
Proceeds from issuance of Senior Notes                     0
2013 Senior Notes | Eliminations                      
Financing Activities                      
Proceeds from issuance of Senior Notes                     0
2016 Senior Notes                      
Financing Activities                      
Proceeds from issuance of Senior Notes                 350,000 0 0
2016 Senior Notes | Prestige Brands Holdings, Inc.                      
Financing Activities                      
Proceeds from issuance of Senior Notes                 0    
2016 Senior Notes | Prestige Brands, Inc., the issuer                      
Financing Activities                      
Proceeds from issuance of Senior Notes                 350,000    
2016 Senior Notes | Combined Subsidiary Guarantors                      
Financing Activities                      
Proceeds from issuance of Senior Notes                 0    
2016 Senior Notes | Combined Non-Guarantor Subsidiaries                      
Financing Activities                      
Proceeds from issuance of Senior Notes                 0    
2016 Senior Notes | Eliminations                      
Financing Activities                      
Proceeds from issuance of Senior Notes                 0    
2012 Senior Notes                      
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:                      
Premium payment on Senior Notes                 (10,158) 0 0
Financing Activities                      
Repayment of Senior Notes                 (250,000) 0 0
2012 Senior Notes | Prestige Brands Holdings, Inc.                      
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:                      
Premium payment on Senior Notes                 0    
Financing Activities                      
Repayment of Senior Notes                 0    
2012 Senior Notes | Prestige Brands, Inc., the issuer                      
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:                      
Premium payment on Senior Notes                 (10,158)    
Financing Activities                      
Repayment of Senior Notes                 (250,000)    
2012 Senior Notes | Combined Subsidiary Guarantors                      
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:                      
Premium payment on Senior Notes                 0    
Financing Activities                      
Repayment of Senior Notes                 0    
2012 Senior Notes | Combined Non-Guarantor Subsidiaries                      
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:                      
Premium payment on Senior Notes                 0    
Financing Activities                      
Repayment of Senior Notes                 0    
2012 Senior Notes | Eliminations                      
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:                      
Premium payment on Senior Notes                 0    
Financing Activities                      
Repayment of Senior Notes                 0    
2010 Senior Notes                      
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:                      
Premium payment on Senior Notes                 0 0 (15,527)
Financing Activities                      
Repayment of Senior Notes                 $ 0 $ 0 (250,000)
2010 Senior Notes | Prestige Brands Holdings, Inc.                      
Financing Activities                      
Repayment of Senior Notes                     0
2010 Senior Notes | Prestige Brands, Inc., the issuer                      
Financing Activities                      
Repayment of Senior Notes                     (250,000)
2010 Senior Notes | Combined Subsidiary Guarantors                      
Financing Activities                      
Repayment of Senior Notes                     0
2010 Senior Notes | Combined Non-Guarantor Subsidiaries                      
Financing Activities                      
Repayment of Senior Notes                     0
2010 Senior Notes | Eliminations                      
Financing Activities                      
Repayment of Senior Notes                     $ 0